NCT01154361View on ClinicalTrials.gov

AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Angioedema
Interventions
DRUG

Icatibant (subcutaneous) and plazebo (intravenous)

DRUG

Cortisone + Clemastin (intravenous) and plazebo (subcutaneous)

Trial Locations (1)

81675

Klinikum rechts der Isar Hals-Nasen-Ohrenklinik der TUM, Munich

All Listed Sponsors
lead

Technical University of Munich

OTHER

NCT01154361 - AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study | Biotech Hunter | Biotech Hunter